Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
100 mg | Inquiry | Backorder | |
500 mg | Inquiry | Backorder |
Description | AcLysValCit-PABC-DMAE-SW-163D is a drug-linker conjugate for antibody-drug conjugates (ADCs), incorporating the natural bis-intercalator SW-163D through an AcLysValCit-PABC-DMAE linker[1]. |
In vitro | SW-163D, a cyclodepsipeptide antibiotic sourced from Streptomyces sp., demonstrates antitumor properties. PF06888667, characterized as a potent, stable, and effective Antibody-Drug Conjugate (ADC), comprises SW-163D linked to an engineered variant of trastuzumab, an anti-Her2 monoclonal antibody (mAb), through an N-acetyl-lysine-valine-citrulline-p-aminobenzyl alcohol-N,N-dimethylethylenediamine (AcLysValCitPABC-DMAE) linker. This conjugation is facilitated by transglutaminase. |
Molecular Weight | 1817.07 |
Formula | C85H113N19O22S2 |
Cas No. | 2411007-69-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.